284 related articles for article (PubMed ID: 30269265)
21. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.
Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopien B
Endocrine; 2016 Jul; 53(1):291-8. PubMed ID: 26902871
[TBL] [Abstract][Full Text] [Related]
22. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
Lu CC; Hsieh CJ
Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
[TBL] [Abstract][Full Text] [Related]
23. Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.
Ke X; Wang L; Duan L; Yang H; Yin J; Qiu L; Pan H; Gong F; Zhu H
Clin Chim Acta; 2023 Apr; 544():117358. PubMed ID: 37086942
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.
Tamer G; Telci A; Mert M; Uzum AK; Aral F; Tanakol R; Yarman S; Boztepe H; Colak N; Alagöl F
Endocrine; 2012 Feb; 41(1):138-43. PubMed ID: 21959531
[TBL] [Abstract][Full Text] [Related]
25. Serum prolactin and macroprolactin levels in diabetic nephropathy.
Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
[TBL] [Abstract][Full Text] [Related]
26. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
27. [Screening and detection of patients with macroprolactinemia by application of polyethylene glycol precipitation method].
Chen YJ; Zhou YL; Xu L; Yan J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):187-92. PubMed ID: 24782376
[TBL] [Abstract][Full Text] [Related]
28. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
Tütüncüler F; Darendeliler F; Aygün M; Hekim N
Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
[TBL] [Abstract][Full Text] [Related]
29. [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].
Lakatos G; Szücs N; Kender Z; Czirják S; Rácz K
Orv Hetil; 2010 Jun; 151(26):1072-5. PubMed ID: 20558354
[TBL] [Abstract][Full Text] [Related]
30. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
31. Macroprolactinemia, like hyperprolactinemia, may promote platelet activation.
Anaforoglu I; Ertorer ME; Kozanoglu I; Unal B; Haydardedeoglu FE; Bakiner O; Bozkirli E; Tutuncu NB; Demirag NG
Endocrine; 2010 Apr; 37(2):294-300. PubMed ID: 20960266
[TBL] [Abstract][Full Text] [Related]
32. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia.
Alfonso A; Rieniets KI; Vigersky RA
Endocr Pract; 2006; 12(3):275-80. PubMed ID: 16772199
[TBL] [Abstract][Full Text] [Related]
33. Macroprolactin: From laboratory to clinical practice.
Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561
[TBL] [Abstract][Full Text] [Related]
34. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
[TBL] [Abstract][Full Text] [Related]
35. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
36. Persistent Idiopathic Prolactin Elevation Merits Macroprolactin Estimation: A Case Report and Review of Literature.
Gautam K; Cherian KE; Jose A; Aleyamma TK; Kapoor N; Paul TV
J Hum Reprod Sci; 2021; 14(2):206-210. PubMed ID: 34316240
[TBL] [Abstract][Full Text] [Related]
37. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
[TBL] [Abstract][Full Text] [Related]
38. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
[TBL] [Abstract][Full Text] [Related]
39. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
40. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
Chen Y; Wang H; Yang W; Jin W; Yu W; Wang W; Zhang K; Song G
J Clin Lab Anal; 2016 Nov; 30(6):1169-1174. PubMed ID: 27219457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]